FDA Downclassifies Multiplex Nucleic Acid Assays
This article was originally published in The Gray Sheet
Executive Summary
FDA has decided to relax its classification of multiplex nucleic acid assays to detect microorganisms and resistance markers in the blood but with special controls to mitigate concerns with potential to misinterpret test results.